$3.10
00.00%
Pre-Market: 8:00 AM EDT
Comments
Loading...
Galmed Pharmaceuticals (NASDAQ:GLMD) Stock, Earnings Estimates, EPS, And Revenue
Galmed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 30
EPS
$-2.760
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Galmed Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Galmed Pharmaceuticals (GLMD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-04 | $-11.76 | $-3.84 | -206.3 % |
| Sep 2023 | 2023-11-22 | $-2.88 | $-3.60 | 20.0 % |
| Jun 2023 | 2023-08-09 | $-11.40 | $-4.08 | -179.4 % |
| Mar 2023 | 2023-06-01 | $-13.08 | $-18.00 | 27.3 % |
Galmed Pharmaceuticals (GLMD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Galmed Pharmaceuticals (NASDAQ:GLMD) reporting earnings?
Galmed Pharmaceuticals (GLMD) is scheduled to report earnings on November 29, 2024. The last reported earnings were for reported on May 30, 2024 for Q1.
What were the latest earnings per share (EPS) for Galmed Pharmaceuticals (NASDAQ:GLMD)?
The Actual EPS was $-2.76, which missed the estimate of $0.00.
What were Galmed Pharmaceuticals’s (NASDAQ:GLMD) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.